RUZZA, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 3.168
EU - Europa 769
AS - Asia 517
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.467
Nazione #
US - Stati Uniti d'America 3.165
CN - Cina 245
IT - Italia 232
PL - Polonia 154
SG - Singapore 136
UA - Ucraina 113
TR - Turchia 83
DE - Germania 82
GB - Regno Unito 74
FI - Finlandia 38
SE - Svezia 36
ID - Indonesia 33
BE - Belgio 14
CZ - Repubblica Ceca 8
IN - India 7
BR - Brasile 6
RU - Federazione Russa 6
FR - Francia 4
PE - Perù 4
CA - Canada 3
JP - Giappone 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DK - Danimarca 2
HK - Hong Kong 2
RO - Romania 2
VN - Vietnam 2
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
ES - Italia 1
IR - Iran 1
KR - Corea 1
KW - Kuwait 1
MY - Malesia 1
NL - Olanda 1
NO - Norvegia 1
PH - Filippine 1
Totale 4.467
Città #
Fairfield 498
Woodbridge 401
Ashburn 283
Houston 224
Seattle 211
Cambridge 194
Ann Arbor 183
Wilmington 183
Chandler 161
Warsaw 154
Jacksonville 152
Ferrara 121
Singapore 112
Shanghai 59
Princeton 57
Beijing 54
Izmir 53
Nanjing 44
Milan 40
New York 36
Jakarta 33
San Diego 32
Dearborn 31
Los Angeles 28
Santa Clara 28
Boardman 27
Addison 15
Brussels 14
Nanchang 14
Shenyang 13
Falls Church 12
Helsinki 11
Norwalk 11
Bremen 9
London 8
Redwood City 8
Washington 8
Changsha 7
Hebei 7
Padova 7
Bari 6
Ferrara di Monte Baldo 6
Jiaxing 6
Mountain View 6
Auburn Hills 5
Bologna 5
San Mateo 5
Tappahannock 5
Brno 4
Cagliari 4
Jena 4
Lima 4
Munich 4
Ningbo 4
Olomouc 4
Orange 4
Tianjin 4
Augusta 3
Grassano 3
Hounslow 3
Islington 3
Lanzhou 3
Redmond 3
Zhengzhou 3
Bucharest 2
Catania 2
Dong Ket 2
Fort Huachuca 2
Guangzhou 2
Haikou 2
Hefei 2
Hong Kong 2
Indiana 2
Jinan 2
Juiz De Fora 2
La Canada Flintridge 2
Leawood 2
Monmouth Junction 2
Mumbai 2
Philadelphia 2
Prescot 2
Pune 2
Scorzè 2
Torino 2
Toronto 2
Walnut 2
Aberdeen 1
Amsterdam 1
Ardabil 1
Belo Horizonte 1
Bonn 1
Boston 1
Castellana Grotte 1
Changchun 1
Chicago 1
Chiswick 1
Davao City 1
Des Moines 1
Dhaka 1
Falkenstein 1
Totale 3.702
Nome #
Pharmacological and neurobiological studies on Neuropeptide S and its receptor 185
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor 148
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 135
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 134
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 132
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 130
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 128
Modulation of the NOP receptor signaling affects resilience to acute stress 128
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 126
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 119
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 115
Pharmacological characterization of tachykinin tetrabranched derivatives 113
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 112
Structure-activity study at positions 3 and 4 of human neuropeptide S. 112
null 110
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 109
Neuropeptide S receptor ligands: a patent review (2005-2016) 107
null 105
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 104
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 101
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 99
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 97
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 95
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 93
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 93
null 87
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 86
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 85
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 82
NOP agonist action of cebranopadol counteracts its liability to promote physical dependence 80
NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine 78
null 77
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 77
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS. 68
Dopamine D1 and D2 receptors mediate neuropeptide S-induced antinociception in the mouse formalin test 64
Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors 63
Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test 58
NOP Ligands for the Treatment of Anxiety and Mood Disorders 58
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 50
Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders 45
Blockade of nociceptin/orphanin FQ signaling facilitates an active copying strategy due to acute and repeated stressful stimuli in mice 45
Novel Mixed NOP/Opioid Receptor Peptide Agonists 43
null 42
Detailed in vitro pharmacological characterization of the clinically viable nociceptin/orphanin FQ peptide receptor antagonist BTRX-246040 39
Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress 38
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 37
The concise guide to pharmacology 2019/20: G protein-coupled receptors 35
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists 33
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 30
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 30
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 29
Biased versus Partial Agonism in the Search for Safer Opioid Analgesics 27
Pharmacological characterization of naloxegol: In vitro and in vivo studies 25
Blockade of nociceptin/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice 21
The concise guide to pharmacology 2021/22: G protein-coupled receptors 19
Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acid 18
Pharmacology, physiology and genetics of the neuropeptide s system 18
Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors 16
Preclinical effects of cannabidiol in an experimental model of migraine 15
The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus 15
Nociceptin/orphanin FQ receptor system blockade as an innovative strategy for increasing resilience to stress 13
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation 11
In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay 6
Activation of NOP receptor increases vulnerability to stress: role of glucocorticoids and CRF signaling 4
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors 1
The concise guide to pharmacology 2017/18: Overview 1
Totale 4.599
Categoria #
all - tutte 25.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 448
Totale 26.115


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020908 0 0 0 143 92 145 141 110 106 89 52 30
2020/2021799 45 87 55 72 49 81 66 78 41 102 74 49
2021/2022524 33 35 28 39 37 38 27 41 24 52 35 135
2022/2023455 58 42 23 48 58 44 39 37 50 5 27 24
2023/2024427 32 47 25 14 26 78 22 39 4 21 14 105
2024/2025239 43 43 153 0 0 0 0 0 0 0 0 0
Totale 4.599